Connect with us

Technology

New Report from Clarivate and Healthcare Executive Explores Mainland China’s Biopharma Revolution and Increasing Global Influence

Published

on

New report analyses Mainland China’s transformation into a global biopharma powerhouse, with key insights for international stakeholders

LONDON, Nov. 18, 2024 /CNW/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come.

Over the past decade, Mainland China’s biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches. Driven by reforms, increased investment, and progressive policies, the industry has reduced approval timelines, raised regulatory standards, and improved patient access to advanced therapies. Insights from the Institute for Scientific Information™ show that China’s Gross Expenditure on Research and Development has grown 3.5 times over the past decade, outpacing growth rates in the UK and the U.S.1 These developments, combined with an evolving healthcare reimbursement system, have enabled both domestic and multinational companies to bring new therapies to market, benefiting millions of patients.

Henry Levy, President, Life Sciences & Healthcare, Clarivate, said: “Mainland China’s ascent in the biopharma sector reflects the power of sustained investment and strategic reform. This report not only highlights the impressive achievements of the past decade but also underlines the far-reaching potential for Chinese biopharma companies to drive global medical innovation and enhance patient outcomes worldwide.”

Tan Yong, Vice President of China Pharmaceutical Enterprises Association and Publisher of Healthcare Executive, noted: “The pharmaceutical industry is poised for significant and transformative changes in the upcoming decade, driven by heightened competition. Rapid innovation and intense competition have reshaped market dynamics, leading to more focused and sustainable growth. The report offers the industry a glimpse of how Chinese pharmaceutical companies can prioritize innovation and international expansion in the next decade.”

Alice Zeng, Senior Solution Consultant, Life Sciences & Healthcare, Clarivate, added: “This report is an invaluable resource for global industry stakeholders. For pharma companies worldwide, it provides a timely understanding of Mainland China’s biopharma landscape, covering the opportunities for international collaboration and the potential for accelerated market entry.”

The report highlights Mainland China’s regulatory advancements, rapid drug launch growth, and expanding domestic R&D role. Key updates include the National Reimbursement Drug List (NRDL), where systematic price negotiations have cut costs by 50-60%, improving access to innovative drugs. Additionally, Mainland China’s share of global licensing and service deals has grown from 6.5% to nearly 9% since 2015, and the country now leads in publishing research and filing patents in key life sciences, underscoring its rising influence on the global industry.

Key insights in A Decade of Innovation, A Decade to Come, include:

Impactful policy reforms: How regulatory initiatives such as the Marketing Authorization Holder (MAH) system and priority review programs have streamlined approvals and bolstered R&D.Healthcare accessibility and innovation: An examination of Mainland China’s healthcare reforms, including the expansion of the NRDL and commercial health insurance, increasing access to cutting-edge therapies.Investment and R&D growth: Analysis of Mainland China’s record-breaking R&D investment, driving advancements in oncology, anti-infectives, and emerging therapeutic areas.Global Integration and market opportunities: Insights into the rise of Mainland China’s biopharma sector as a global player, including the increase in multinational collaborations and first-to-market launches.

With Mainland China’s share of first-time global drug launches growing, and as new therapeutic areas advance, A Decade of Innovation, A Decade to Come provides timely, in-depth insights for international investors, multinational pharmaceutical companies, and healthcare stakeholders who seek to understand Mainland China’s role in shaping the future of the biopharma landscape.

The A Decade of Innovation, A Decade to Come report draws on comprehensive data and tools trusted by the global life sciences community, including Cortellis Competitive Intelligence, Cortellis Regulatory Intelligence™, Disease Landscape & Forecast, Cortellis Deals Intelligence, Cortellis Clinical Trials Intelligence™, Cortellis Product Intelligence™, Real World Data and Analytics, Access and reimbursement payer studies, BioWorld™, Web of Science™ and Derwent Innovation™ among others. Compiled by Clarivate analysts using data gathered prior to August 31, 2024, this report reflects Clarivate’s commitment to supporting drug, device, and medical technology lifecycles. By combining patient journey data, therapeutic insights, and AI-driven analytics, Clarivate enables evidence-based decisions that advance human health.

To learn more about the Clarivate report, A Decade of Innovation, A Decade to Come, visit here.

About Healthcare Executive
With media as the outpost, conference as the platform, live video broadcasting as the tool, and expert pharmaceutical industry observers and recorders as the living force, Healthcare Executive (E药经理人) brings the top consensus of entrepreneurs, scientists, and investors in the pharmaceutical industry together on the one hand, and on the other hand gathers multi-dimensional and multi-level resources from the whole industry chain. We are dedicated to providing in-depth professional communication opportunities and influential solutions for the whole industry chain in their whole life cycle. In this regard, we make connections with client requirements upstream and downstream and make preparations for the overseas strategy in their international programs.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact 
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Clarivate
newsroom@clarivate.com

1 Source: Global Research Report: China’s research landscape, ISI, Clarivate

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-report-from-clarivate-and-healthcare-executive-explores-mainland-chinas-biopharma-revolution-and-increasing-global-influence-302307317.html

SOURCE Clarivate Plc

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Big Frog Custom T-Shirts & More Ends 2024 With Steady Growth and Major Innovations

Published

on

By

Big Frog celebrates a year of progress with five new locations, the launch of an e-commerce solution and additional initiatives to enhance franchisee success nationwide.

DUNEDIN, Fla.  , Jan. 15, 2025 /PRNewswire-PRWeb/ — Big Frog Custom T-Shirts & More, a leader in custom apparel franchising with over 75 locations across the U.S., is celebrating a successful 2024 full of new initiatives and growth.

“Our focus in 2024 was on launching and refining our new point-of-sale system, a critical investment in the future of our franchisees,” said Tina Bacon-DeFrece, founder and CEO of Big Frog. “This initiative laid the foundation for even greater success as we continue to enhance operations and support our stores.”

Revenue growth for the year was approximately 5%, supported by robust digital marketing efforts and the introduction of Big Frog’s Success Program, which encourages franchisees to engage more actively in marketing planning. Stores that followed their plans closely experienced notable growth, showcasing the program’s potential.

Five new franchise locations opened in 2024, including exciting expansions into Stockton, California, and Albuquerque, New Mexico. Although two additional locations were delayed due to permitting issues, they are set to open in early 2025.

“This year marked exciting expansion for Big Frog, including our first locations in Northern California and New Mexico,” said Bacon-DeFrece. “Our growth strategy, under the leadership of our new chief development officer, David Braun, is heavily focused on leveraging broker networks, digital initiatives, public relations, and organic search. It really has ignited interest across the country in our brand. We’re thrilled to expand into new regions while also strengthening our presence in areas like Florida, where local support is right in our backyard.”

Complementing these development efforts have been Big Frog’s existing franchisees, which have proven to be an excellent referral source and point of validation for prospective owners interested in the brand.

“We’ve refined our process over the years and now set up formal calls, which have been really nice for candidates because it sets expectations and dedicated times for them to speak one-on-one with our franchisees,” Bacon-DeFrece said. “That’s really made the validation process a lot easier for everyone since there is less back and forth.”

Big Frog is also taking a major step forward in leveraging technology to enhance its services and support franchisees. This year, the company focused on developing an innovative e-commerce platform that combines the convenience of online shopping with the personal touch of local fulfillment, setting the stage for its beta launch.

“Our e-commerce initiative has been one of the most exciting projects for Big Frog this year,” said Bacon-DeFrece. “We’re in the process of launching a national platform where customers can design and purchase custom apparel online, with fulfillment handled by our local stores. A key priority for us is ensuring fair revenue distribution across all locations, so every franchisee benefits whether they’re in a major metro area or a smaller market.”

In custom apparel trends, the brand saw increased demand for high-end corporate products like Carhartt and North Face items, as well as continued interest in promotional products. These offerings cater to clients seeking premium-quality branded merchandise.

“We now have access to a lot of those types of blank apparel to decorate,” said Bacon-DeFrece. “Our B2B customers really like that they get some really high end products, either for corporate gifts or for their team.”

Looking ahead to 2025, Big Frog aims to achieve double-digit revenue growth for its stores while exploring advancements in artificial intelligence to simplify store operations. The e-commerce solution, once fully launched, is expected to play a pivotal role in boosting franchisee revenue.

ABOUT BIG FROG CUSTOM T-SHIRTS & MORE:
Founded in 2008 and headquartered in Dunedin, Florida, Big Frog Custom T-Shirts and More, Inc. is an international franchise system with over 75 independently owned and operated stores serving consumers and businesses across the U.S. and Canada. Big Frog specializes in direct to garment printing (DTG) and is a one-stop shop for all custom apparel decorating techniques, as well as branded promotional products. Big Frog offers free design help, no minimums, no art/setup fees, and fast turnaround. Find a store at BIGFROG.COM, U.S. franchise opportunities at BIGFROGFRANCHISE.COM, Canadian franchise opportunities at BIGFROG.CA, and Big Frog on YouTube.

Media Contact

Chad Cohen, Mainland, 3125263996, ccohen@hellomainland.com, www.hellomainland.com 

View original content:https://www.prweb.com/releases/big-frog-custom-t-shirts–more-ends-2024-with-steady-growth-and-major-innovations-302351517.html

SOURCE Big Frog Custom T-Shirts & More

Continue Reading

Technology

New Website Helps Consumers Navigate an Important Battery Choice for their EV or Hybrid Vehicle

Published

on

By

East Penn has developed a new website to help navigate through the new ways batteries are being used in EV and Hybrid vehicles.

LYON STATION, Pa., Jan. 15, 2025 /PRNewswire-PRWeb/ — East Penn has developed a new website to help navigate through the new ways batteries are being used in EV and Hybrid vehicles. These vehicles are more complex with different battery voltage systems within the same vehicle. They use both lithium and lead battery solutions, which are dependent on each other to operate a vehicle.

The lithium batteries that power the high voltage system are designed by the automotive manufacturer and most likely last for the life of the vehicle. However, the battery for the low voltage system will eventually need to be replaced. Making the right choice when replacing the 12-volt battery will protect both voltage systems. The battery that’s chosen could either enhance or hinder the overall performance and safety of the EV or Hybrid vehicle over time.

Traditional vehicles use a 12-volt battery to start the engine and to stabilize the electronics. Electric and Hybrid vehicles use the 12-volt battery for all types of safety critical and auxiliary power reasons. Here are a few:

Start-stop functions in micro hybridsStarting assistPowering cabin accessoriesSteer-by-wire power backupBrake-by-wire power backupOther smart controls or enhanced functions

It is more important than ever that the consumer understands the capabilities of the replacement battery for their EV or Hybrid. Battery manufacturers and distributors are beginning to designate their products so that the consumer has the reassurance that they have the right type of replacement battery to meet these safety-critical demands. East Penn has designated its Deka Intimidator line of AGM batteries with the EHP symbol that stands for Electric Hybrid Performance to help give the consumer added reassurance. It’s also important to note, that these lead batteries have achieved the highest Recycled Content (98%) Environmental validation from UL further accrediting them as one of the most sustainable products in the world.

East Penn is a leading manufacturer of high-quality lead batteries and accessories for the automotive, commercial, marine, motive power, UPS, and telecommunication markets. The company’s quality and environmental systems for its entire 520-acre complex have been certified to ISO 9001:2015, ISO/TS 16949:2016, and ISO 14001:2015 requirements. To learn more about the company visit https://www.eastpennmanufacturing.com. To learn more about the power you have to recycle visit https://www.eastpennmanufacturing.com/power2recycle.

Media Contact

Joel Brady, East Penn Manufacturing, Co., 1 610-682-6361 2740, jbrady@dekabatteries.com, https://www.eastpennmanufacturing.com/

View original content to download multimedia:https://www.prweb.com/releases/new-website-helps-consumers-navigate-an-important-battery-choice-for-their-ev-or-hybrid-vehicle-302351570.html

SOURCE East Penn Manufacturing, Co.

Continue Reading

Technology

Get Covered Welcomes Dharmesh Shroff as VP of Engineering

Published

on

By

NEW YORK, Jan. 15, 2025 /PRNewswire/ — Get Covered, a leading renters insurance technology company, is thrilled to announce the appointment of Dharmesh Shroff as VP of Engineering. Dharmesh brings over 18 years of experience driving technology innovation in the PropTech space, where he has consistently delivered scalable platforms and seamless integrations.

“We are excited to welcome Dharmesh to the Get Covered family,” said CEO, Brandon Tobman. “His deep expertise in building robust integrations and API ecosystems will be instrumental as we continue to redefine the renter’s insurance experience for our customers and partners and expand our offering.”

Proven Expertise in Technology Leadership

Dharmesh joins Get Covered following a distinguished career that includes serving as SVP of Engineering at Entrata and other leading Property Management Systems companies. “I’m excited about the opportunity to bring transformative technology to the insurance industry, much like I did in the PropTech space,” Dharmesh said. “The parallels between PropTech and InsurTech—both dealing with highly fragmented data and the need for seamless integrations—make this an exciting new challenge.”

Vision for the Future

As VP of Engineering, Dharmesh aims to enhance the customer experience by advancing real-time data integration, incorporating AI-driven capabilities for smarter interactions, and setting new standards for API security and interoperability. His goal is to help create a highly adaptable integration framework that empowers partners and developers while delivering faster, more personalized insurance solutions.

“APIs are more than just tools; they’re the backbone of connected, smarter customer experiences,” Dharmesh explained.

Building on a Culture of Excellence

In addition to his technical expertise, Dharmesh is known for his leadership in building world-class engineering teams. At Pattern he hired over 95 employees across development roles, while at Entrata, he built a robust operation which grew to over 800 employees.

“Attracting and retaining top talent starts with creating a culture of innovation, ownership, and growth,” Dharmesh said.

Dharmesh’s leadership style is also influenced by his commitment to mindfulness, which helps him stay empathetic, focused, and resilient in high-pressure situations.

About Get Covered

Get Covered is revolutionizing the renters insurance industry with cutting-edge technology that simplifies the insurance process for tenants, landlords, and property managers. By combining innovative solutions with a customer-centric approach, Get Covered is setting a new standard for insurance technology.

For more information about Get Covered and its leadership team, visit www.getcovered.io

View original content to download multimedia:https://www.prnewswire.com/news-releases/get-covered-welcomes-dharmesh-shroff-as-vp-of-engineering-302349793.html

SOURCE Get Covered

Continue Reading

Trending